Company name Myriad Genetics, Inc.
Stock symbol MYGN
Class period August 13, 2014 – March 12, 2018
Lead plaintiff deadline June 19, 2018
Court District of Utah
Status Under Investigation

NEW YORK, April 23, 2018 – Bragar Eagel & Squire, P.C. announces to investors that a class action lawsuit has been filed in the U.S. District Court for the District of Utah on behalf of all persons or entities who purchased or otherwise acquired Myriad Genetics, Inc. (NASDAQ: MYGN) securities between August 13, 2014 and March 12, 2018 (the “Class Period”).  Investors have until June 19, 2018 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

On March 12, 2018, Myriad announced that the Company had recently received a Subpoena from the Department of Health and Human Services, Office of Inspector General, in connection with an investigation into possible false or otherwise improper claims submitted for payment under Medicare and Medicaid. The Subpoena requested that the Company produce documents relating primarily to the Company’s billing to government-funded healthcare programs for the Company’s hereditary cancer testing.

Following this news, shares of Myriad fell $4.01 per share, or 12.1%, to close at $29.01 on March 13, 2018.

If you purchased or otherwise acquired Myriad securities during the Class Period or continue to hold shares purchased prior to the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.

Join the action by filling out the form below

First name*

Last name*

City, state ZIP code

Email address*

Daytime phone

Evening phone

Purchase Date

No. of Shares

Purchase Price

Purchase Date

No. of Shares

Purchase Price

Join action?

Call to provide more information: Tel: (212) 308-4648

Please list below any additional transactions in this security:

Additional comments

The submission of this form does not create an attorney-client relationship, nor any obligation on the part of Bragar Eagel & Squire, P.C., or you to file a legal action. Any information you submit will be maintained as confidential. If Bragar Eagel & Squire, P.C., in its sole discretion, believes that you might be an appropriate class representative, Bragar Eagel & Squire, P.C., will contact you to discuss the matter and to determine whether to establish an attorney client relationship.